Status
Conditions
Treatments
About
This is a 3 year longitudinal study to identify novel endpoints and compare these with standard measures such as forced expiratory volume in 1 second (FEV1) for their ability to measure and predict COPD (Chronic Obstructive Pulmonary Disease) severity and its progression over time. Control subjects (smokers and never smokers) will be recruited as comparators with the COPD subjects.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Control Subjects - Current/Ex Smokers
Control Subjects - Non-smokers
Exclusion criteria
COPD Subjects
Control Subjects
2,747 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal